P. Ciuffreda et al. / Tetrahedron: Asymmetry 15 (2004) 203–206
205
NH2
N
NH2
N
OH
N
N
N
N
N
N
N
H
H
N
N
N
R
HO
HO
OH
O
R
R
O
O
AMPDA
O
O
O
O
O
O
R= CH3, C3H9
(R,S)-3b,c
(S)-4b,c
(R)-3b,c
Figure 4.
3c and the corresponding (50S)-50-butyl-20,30-isopropyl-
idene inosine (50S)-4c.
2. Ciuffreda, P.; Loseto, A.; Santaniello, E. Tetrahedron:
Asymmetry 2002, 13, 239–241.
ꢁ
3. Chladek, S.; Smrt, J. Collect. Czech. Chem. Commun.
1964, 29, 214–232.
4. Compound 5: 1H NMR (CDCl3) d 9.29 (1H, s, NH), 8.74
(1H, s, H-8), 8.09 (1H, s, H-2), 8.00 (2H, d, J ¼ 7:7,
o-PhH), 7.58 (1H, dd, J ¼ 7:7, 7.7 Hz, m-PhH), 7.42 (2H,
t, J ¼ 7:7 Hz, p-PhH), 5.95 (1H, d, J ¼ 5:6 Hz, H-10), 5.21
(1H, dd, J ¼ 5:6, 5.6 Hz, H-20), 5.09 (1H, dd, J ¼ 1:4,
5.6 Hz, H-30), 4.55 (1H, ddd, J ¼ 1:4, 1.4, 2.1 Hz, H-40),
3.98 (1H, dd, J ¼ 1:4, 12.6 Hz, H-50a), 3.80 (1H, dd,
J ¼ 2:1, 12.6 Hz, H-50b), 1.63 (3H, s, CCH3), 1.36 (3H, s,
CCH3).
5. Vrudhula, V. M.; Kappler, F.; Afshar, C.; Ginell, S. L.;
Lessinger, L.; Hampton, A. J. Med. Chem. 1989, 32, 885–
890.
6. Shuto, S.; Obara, T.; Toriya, M.; Hosoya, M.; Snoeck, R.;
Andrei, G.; Balzarini, J.; De Clercq, E. J. Med. Chem.
1992, 35, 324–331.
3. Conclusions
Our results show that ADA and AMPDA are able to
catalyze the deamination of a 20,30-isopropylidene
adenosine in a stereoselective fashion when a methyl
group is present at the 50-position. For both enzymes,
the (50S)-isomer is preferentially deaminated to the
corresponding inosine derivative and the unreacted
(50R)-adenosine may be recovered. This result may
constitute an additional example of the application of
two important biocatalysts in the nucleoside area for
chemo-enzymatic preparation of modified purine
nucleosides. In contrast to AMPDA, ADA seems more
sensitive to the steric hindrance at the 50 position, since
this enzyme is unable to catalyze the deamination of
(50R,S)-50-butyl derivative 3c. However, the high reac-
tion rate observed for AMPDA-catalyzed conversion of
50-butyl derivative 3c raises another interesting question.
In fact, at the pH required for the enzymatic transfor-
mation of the physiological substrate of AMPDA, that
is AMP, the phosphate at the position 50 should be in the
anionic form and AMPDA should accept ionic or polar
substituents at that position. This is in contrast with the
results obtained with the 50-butyl derivative 3c and other
nucleosides bearing apolar substituents at the
50-position.1 The results obtained so far highlight also a
main difference in the action of the AMPDA, compared
to the other deaminating enzyme ADA.
7. Ranganathan, R. S.; Jones, G. H.; Moffatt, J. G. J. Org.
Chem. 1974, 39, 290–297.
8. The most significant signals for compound 6 are: 8.70 (1H,
s, H-8), 7.86 (1H, s, H-2), 6.16 (1H, d, J ¼ 2:1 Hz, H-10),
5.72 (1H, d, J ¼ 2:8 Hz, H-50), 5.20 (1H, dd, J ¼ 6:3,
6.3 Hz, H-30), 5.16 (1H, dd, J ¼ 2:1, 6.3 Hz, H-20), 4.62
(1H, dd, J ¼ 2:8, 6.3 Hz, H-40) 1.47 (3H, s, CCH3), 1.31
(3H, s, CCH3).
9. Compounds 3b,c (0.02 g) in phosphate buffer (50 mM,
6 mL, pH 6.5) with 3% DMSO were treated with AMPDA
(from Aspergillus species, Sigma, 0.107 units/mg solid,
20 mg) for the time indicated in the text. The progress of
reactions was monitored by HPLC (3b: phosphate buffer
pH 6.0/CH3 CN, 8:2; 3c: phosphate buffer pH 6.0/CH3
CN, 7:3). When the reaction was complete, the solution
was lyophilized to afford inosines 4b,c.
10. 3c, major diastereomer: HPLC tR ¼ 18:5 min (phosphate
buffer pH 6.0/CH3CN, 7:3); 1H NMR (CD3OD) d 8.28
(1H, s, H-8), 8.19 (1H, s, H-2), 6.11 (1H, d, J ¼ 3:4 Hz, H-
10), 5.25 (1H, dd, J ¼ 3:4, 6.0 Hz, H-20), 5.07 (1H, dd,
J ¼ 2:7, 6.0 Hz, H-30), 4.15 (1H, dd, J ¼ 2:7, 3.4 Hz,
H-40), 3.74 (1H, dt, J ¼ 3:4, 4.0 Hz, H-50), 1.60 (3H, s,
CCH3), 1.54–1.41 (m, 2H, CH2), 1.35–1.23 (m, 4H,
CH2 · 2), 1.38 (3H, s, CCH3), 0.87 (3H, t, J ¼ 6:0 Hz,
CH3); minor diastereomer: HPLC tR ¼ 17:2 min (phos-
Acknowledgements
ꢀ
This work has been financially supported by Universita
degli Studi di Milano (Fondi FIRST).
1
phate buffer pH 6.0/CH3 CN, 7: 3); H NMR (CD3OD) d
8.36 (1H, s, H-8), 8.18 (1H, s, H-2), 6.13 (1H, d,
J ¼ 3:4 Hz, H-10), 5.15 (1H, dd, J ¼ 3:4, 6.0 Hz, H-20),
5.00 (1H, dd, J ¼ 2:7, 6.0 Hz, H-30), 4.26 (1H, dd, J ¼ 2:7,
3.4 Hz, H-40), 3.74 (1H, dt, J ¼ 3:4, 4.0 Hz, H-50), 1.61
(3H, s, CCH3), 1.54–1.41 (m, 2H, CH2), 1.35–1.23 (m, 4H,
CH2 · 2), 1.37 (3H, s, CCH3), 0.90 (3H, t, J ¼ 6:0 Hz,
CH3).
References and notes
1. Ciuffreda, P.; Loseto, A.; Santaniello, E. Tetrahedron
2002, 58, 5767–5771.
11. Compound (S)-4c HPLC tR ¼ 10:1 min (phosphate buffer
pH 6.0/CH3CN, 7:3); 1H NMR (CD3OD) d 8.21 (1H, s,